Form D Explorer

Inspect source fieldsReport a record issue

Form D — Trevarx Biomedical, Inc.

0001783904-25-000003 · filed Aug 4, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$750,000
Reported amount sold
$350,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Trevarx Biomedical, Inc.
CIK
1783904
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
2929 ARCH STREET, 3RD FLOOR
PHILADELPHIA, Pennsylvania 19104
Phone
(206) 949-4956

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗